調査レポート | • レポートコード：GIR-2104Z09118 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メルケル細胞癌治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メルケル細胞癌治療の種類別市場規模（化学療法、免疫療法、併用療法、その他）、用途別市場規模（病院、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メルケル細胞癌治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Amgen Inc、Apcure SAS、BeiGene Ltd、Immune Design Corp、Merck & Co Inc、Merck KGaA、Millennium Pharmaceuticals Inc、NantKwest Inc、Novartis AG、OncoSec Medical Inc、Oncovir Inc、Ono Pharmaceutical Co Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、免疫療法、併用療法、その他 ・用途別分析2016年-2026年：病院、外来手術センター、その他 ・メルケル細胞癌治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メルケル細胞癌治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メルケル細胞癌治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メルケル細胞癌治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メルケル細胞癌治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Merkel Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Merkel Cell Carcinoma Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Merkel Cell Carcinoma Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Merkel Cell Carcinoma Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Immunotherapy
Combination Therapies
Others
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centres
Others
Market segment by players, this report covers
Merck
Amgen Inc
Apcure SAS
BeiGene Ltd
Immune Design Corp
Merck & Co Inc
Merck KGaA
Millennium Pharmaceuticals Inc
NantKwest Inc
Novartis AG
OncoSec Medical Inc
Oncovir Inc
Ono Pharmaceutical Co Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Merkel Cell Carcinoma Treatment
1.2 Classification of Merkel Cell Carcinoma Treatment by Type
1.2.1 Overview: Global Merkel Cell Carcinoma Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Merkel Cell Carcinoma Treatment Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Combination Therapies
1.2.6 Others
1.3 Global Merkel Cell Carcinoma Treatment Market by Application
1.3.1 Overview: Global Merkel Cell Carcinoma Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centres
1.3.4 Others
1.4 Global Merkel Cell Carcinoma Treatment Market Size & Forecast
1.5 Global Merkel Cell Carcinoma Treatment Market Size and Forecast by Region
1.5.1 Global Merkel Cell Carcinoma Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Merkel Cell Carcinoma Treatment Market Size by Region, (2016-2021)
1.5.3 North America Merkel Cell Carcinoma Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Merkel Cell Carcinoma Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Merkel Cell Carcinoma Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Merkel Cell Carcinoma Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Merkel Cell Carcinoma Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Merkel Cell Carcinoma Treatment Market Drivers
1.6.2 Merkel Cell Carcinoma Treatment Market Restraints
1.6.3 Merkel Cell Carcinoma Treatment Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Merkel Cell Carcinoma Treatment Product and Solutions
2.1.4 Merck Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Amgen Inc
2.2.1 Amgen Inc Details
2.2.2 Amgen Inc Major Business
2.2.3 Amgen Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.2.4 Amgen Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Inc Recent Developments and Future Plans
2.3 Apcure SAS
2.3.1 Apcure SAS Details
2.3.2 Apcure SAS Major Business
2.3.3 Apcure SAS Merkel Cell Carcinoma Treatment Product and Solutions
2.3.4 Apcure SAS Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Apcure SAS Recent Developments and Future Plans
2.4 BeiGene Ltd
2.4.1 BeiGene Ltd Details
2.4.2 BeiGene Ltd Major Business
2.4.3 BeiGene Ltd Merkel Cell Carcinoma Treatment Product and Solutions
2.4.4 BeiGene Ltd Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BeiGene Ltd Recent Developments and Future Plans
2.5 Immune Design Corp
2.5.1 Immune Design Corp Details
2.5.2 Immune Design Corp Major Business
2.5.3 Immune Design Corp Merkel Cell Carcinoma Treatment Product and Solutions
2.5.4 Immune Design Corp Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Immune Design Corp Recent Developments and Future Plans
2.6 Merck & Co Inc
2.6.1 Merck & Co Inc Details
2.6.2 Merck & Co Inc Major Business
2.6.3 Merck & Co Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.6.4 Merck & Co Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck & Co Inc Recent Developments and Future Plans
2.7 Merck KGaA
2.7.1 Merck KGaA Details
2.7.2 Merck KGaA Major Business
2.7.3 Merck KGaA Merkel Cell Carcinoma Treatment Product and Solutions
2.7.4 Merck KGaA Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck KGaA Recent Developments and Future Plans
2.8 Millennium Pharmaceuticals Inc
2.8.1 Millennium Pharmaceuticals Inc Details
2.8.2 Millennium Pharmaceuticals Inc Major Business
2.8.3 Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.8.4 Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Millennium Pharmaceuticals Inc Recent Developments and Future Plans
2.9 NantKwest Inc
2.9.1 NantKwest Inc Details
2.9.2 NantKwest Inc Major Business
2.9.3 NantKwest Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.9.4 NantKwest Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 NantKwest Inc Recent Developments and Future Plans
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Merkel Cell Carcinoma Treatment Product and Solutions
2.10.4 Novartis AG Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis AG Recent Developments and Future Plans
2.11 OncoSec Medical Inc
2.11.1 OncoSec Medical Inc Details
2.11.2 OncoSec Medical Inc Major Business
2.11.3 OncoSec Medical Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.11.4 OncoSec Medical Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 OncoSec Medical Inc Recent Developments and Future Plans
2.12 Oncovir Inc
2.12.1 Oncovir Inc Details
2.12.2 Oncovir Inc Major Business
2.12.3 Oncovir Inc Merkel Cell Carcinoma Treatment Product and Solutions
2.12.4 Oncovir Inc Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Oncovir Inc Recent Developments and Future Plans
2.13 Ono Pharmaceutical Co Ltd
2.13.1 Ono Pharmaceutical Co Ltd Details
2.13.2 Ono Pharmaceutical Co Ltd Major Business
2.13.3 Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Product and Solutions
2.13.4 Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Ono Pharmaceutical Co Ltd Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Merkel Cell Carcinoma Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Merkel Cell Carcinoma Treatment Players Market Share
3.2.2 Top 10 Merkel Cell Carcinoma Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Merkel Cell Carcinoma Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Merkel Cell Carcinoma Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Merkel Cell Carcinoma Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Merkel Cell Carcinoma Treatment Revenue Market Share by Application (2016-2021)
5.2 Merkel Cell Carcinoma Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Merkel Cell Carcinoma Treatment Revenue by Type (2016-2026)
6.2 North America Merkel Cell Carcinoma Treatment Revenue by Application (2016-2026)
6.3 North America Merkel Cell Carcinoma Treatment Market Size by Country
6.3.1 North America Merkel Cell Carcinoma Treatment Revenue by Country (2016-2026)
6.3.2 United States Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Merkel Cell Carcinoma Treatment Revenue by Type (2016-2026)
7.2 Europe Merkel Cell Carcinoma Treatment Revenue by Application (2016-2026)
7.3 Europe Merkel Cell Carcinoma Treatment Market Size by Country
7.3.1 Europe Merkel Cell Carcinoma Treatment Revenue by Country (2016-2026)
7.3.2 Germany Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
7.3.3 France Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Merkel Cell Carcinoma Treatment Market Size by Region
8.3.1 Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Region (2016-2026)
8.3.2 China Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8.3.5 India Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Merkel Cell Carcinoma Treatment Revenue by Type (2016-2026)
9.2 South America Merkel Cell Carcinoma Treatment Revenue by Application (2016-2026)
9.3 South America Merkel Cell Carcinoma Treatment Market Size by Country
9.3.1 South America Merkel Cell Carcinoma Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Merkel Cell Carcinoma Treatment Market Size by Country
10.3.1 Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Merkel Cell Carcinoma Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Merkel Cell Carcinoma Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Merkel Cell Carcinoma Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Merkel Cell Carcinoma Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Merkel Cell Carcinoma Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Merkel Cell Carcinoma Treatment Product and Solutions
Table 9. Merck Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Inc Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Inc Major Business
Table 12. Amgen Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 13. Amgen Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Apcure SAS Corporate Information, Head Office, and Major Competitors
Table 15. Apcure SAS Major Business
Table 16. Apcure SAS Merkel Cell Carcinoma Treatment Product and Solutions
Table 17. Apcure SAS Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BeiGene Ltd Corporate Information, Head Office, and Major Competitors
Table 19. BeiGene Ltd Major Business
Table 20. BeiGene Ltd Merkel Cell Carcinoma Treatment Product and Solutions
Table 21. BeiGene Ltd Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Immune Design Corp Corporate Information, Head Office, and Major Competitors
Table 23. Immune Design Corp Major Business
Table 24. Immune Design Corp Merkel Cell Carcinoma Treatment Product and Solutions
Table 25. Immune Design Corp Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck & Co Inc Corporate Information, Head Office, and Major Competitors
Table 27. Merck & Co Inc Major Business
Table 28. Merck & Co Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 29. Merck & Co Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 31. Merck KGaA Major Business
Table 32. Merck KGaA Merkel Cell Carcinoma Treatment Product and Solutions
Table 33. Merck KGaA Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Millennium Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 35. Millennium Pharmaceuticals Inc Major Business
Table 36. Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 37. Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. NantKwest Inc Corporate Information, Head Office, and Major Competitors
Table 39. NantKwest Inc Major Business
Table 40. NantKwest Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 41. NantKwest Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 43. Novartis AG Major Business
Table 44. Novartis AG Merkel Cell Carcinoma Treatment Product and Solutions
Table 45. Novartis AG Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. OncoSec Medical Inc Corporate Information, Head Office, and Major Competitors
Table 47. OncoSec Medical Inc Major Business
Table 48. OncoSec Medical Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 49. OncoSec Medical Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Oncovir Inc Corporate Information, Head Office, and Major Competitors
Table 51. Oncovir Inc Major Business
Table 52. Oncovir Inc Merkel Cell Carcinoma Treatment Product and Solutions
Table 53. Oncovir Inc Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Ono Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors
Table 55. Ono Pharmaceutical Co Ltd Major Business
Table 56. Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Product and Solutions
Table 57. Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Merkel Cell Carcinoma Treatment Revenue (USD Million) by Players (2019-2021)
Table 59. Global Merkel Cell Carcinoma Treatment Revenue Share by Players (2019-2021)
Table 60. Breakdown of Merkel Cell Carcinoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Merkel Cell Carcinoma Treatment Players Head Office, Products and Services Provided
Table 62. Merkel Cell Carcinoma Treatment Mergers & Acquisitions in the Past Five Years
Table 63. Merkel Cell Carcinoma Treatment New Entrants and Expansion Plans
Table 64. Global Merkel Cell Carcinoma Treatment Revenue (USD Million) by Type (2016-2021)
Table 65. Global Merkel Cell Carcinoma Treatment Revenue Share by Type (2016-2021)
Table 66. Global Merkel Cell Carcinoma Treatment Revenue Forecast by Type (2021-2026)
Table 67. Global Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021)
Table 68. Global Merkel Cell Carcinoma Treatment Revenue Forecast by Application (2021-2026)
Table 69. North America Merkel Cell Carcinoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Merkel Cell Carcinoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Merkel Cell Carcinoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Merkel Cell Carcinoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Merkel Cell Carcinoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Merkel Cell Carcinoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Merkel Cell Carcinoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Merkel Cell Carcinoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Merkel Cell Carcinoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Merkel Cell Carcinoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Merkel Cell Carcinoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Merkel Cell Carcinoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Merkel Cell Carcinoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Merkel Cell Carcinoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Merkel Cell Carcinoma Treatment Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Merkel Cell Carcinoma Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Merkel Cell Carcinoma Treatment Picture
Figure 2. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Immunotherapy
Figure 5. Combination Therapies
Figure 6. Others
Figure 7. Merkel Cell Carcinoma Treatment Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centres Picture
Figure 10. Others Picture
Figure 11. Global Merkel Cell Carcinoma Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Merkel Cell Carcinoma Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Region in 2020
Figure 15. North America Merkel Cell Carcinoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Merkel Cell Carcinoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Merkel Cell Carcinoma Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Merkel Cell Carcinoma Treatment Market Drivers
Figure 20. Merkel Cell Carcinoma Treatment Market Restraints
Figure 21. Merkel Cell Carcinoma Treatment Market Trends
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Amgen Inc Recent Developments and Future Plans
Figure 24. Apcure SAS Recent Developments and Future Plans
Figure 25. BeiGene Ltd Recent Developments and Future Plans
Figure 26. Immune Design Corp Recent Developments and Future Plans
Figure 27. Merck & Co Inc Recent Developments and Future Plans
Figure 28. Merck KGaA Recent Developments and Future Plans
Figure 29. Millennium Pharmaceuticals Inc Recent Developments and Future Plans
Figure 30. NantKwest Inc Recent Developments and Future Plans
Figure 31. Novartis AG Recent Developments and Future Plans
Figure 32. OncoSec Medical Inc Recent Developments and Future Plans
Figure 33. Oncovir Inc Recent Developments and Future Plans
Figure 34. Ono Pharmaceutical Co Ltd Recent Developments and Future Plans
Figure 36. Global Merkel Cell Carcinoma Treatment Revenue Share by Players in 2020
Figure 37. Merkel Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Merkel Cell Carcinoma Treatment Revenue Market Share in 2020
Figure 39. Global Top 10 Players Merkel Cell Carcinoma Treatment Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Merkel Cell Carcinoma Treatment Revenue Share by Type in 2020
Figure 42. Global Merkel Cell Carcinoma Treatment Market Share Forecast by Type (2021-2026)
Figure 43. Global Merkel Cell Carcinoma Treatment Revenue Share by Application in 2020
Figure 44. Global Merkel Cell Carcinoma Treatment Market Share Forecast by Application (2021-2026)
Figure 45. North America Merkel Cell Carcinoma Treatment Sales Market Share by Type (2016-2026)
Figure 46. North America Merkel Cell Carcinoma Treatment Sales Market Share by Application (2016-2026)
Figure 47. North America Merkel Cell Carcinoma Treatment Revenue Market Share by Country (2016-2026)
Figure 48. United States Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Merkel Cell Carcinoma Treatment Sales Market Share by Type (2016-2026)
Figure 52. Europe Merkel Cell Carcinoma Treatment Sales Market Share by Application (2016-2026)
Figure 53. Europe Merkel Cell Carcinoma Treatment Revenue Market Share by Country (2016-2026)
Figure 54. Germany Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Merkel Cell Carcinoma Treatment Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Merkel Cell Carcinoma Treatment Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Merkel Cell Carcinoma Treatment Revenue Market Share by Region (2016-2026)
Figure 62. China Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Merkel Cell Carcinoma Treatment Sales Market Share by Type (2016-2026)
Figure 69. South America Merkel Cell Carcinoma Treatment Sales Market Share by Application (2016-2026)
Figure 70. South America Merkel Cell Carcinoma Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Merkel Cell Carcinoma Treatment Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Merkel Cell Carcinoma Treatment Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Merkel Cell Carcinoma Treatment Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Merkel Cell Carcinoma Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally oc…- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…
- 世界のハースル細胞がん治療市場 2021：企業別、地域別、種類・用途別 The Hurthle Cell Carcinoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の頭頸部扁平上皮がん（HNSCC）治療市場規模・現状・予測（2021年-2027年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…